Reynoso Jamie L. 4

What Happened

• Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments (CLOV), sold 13,119 shares on July 15, 2026. The weighted-average sale price was $4.67 per share (range $4.67–$4.72), generating roughly $61,266 in proceeds.
• This transaction was a sale (not a purchase) and was executed as a "sell-to-cover" to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs), not a discretionary trade.

Key Details

• Transaction date: 2026-07-15; weighted-average price reported $4.67 (individual trades $4.67–$4.72).
• Shares sold: 13,119; approximate proceeds: $61,266.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: (1) Sale required to cover tax withholding on 6.25% of RSUs that vested July 15, 2026; RSUs were granted Oct 15, 2024, and remaining RSUs vest quarterly through Oct 15, 2028. (2) Price is a weighted average; details of per-trade prices available on request.
• Filing timeliness: Form filed on 2026-07-16 for a 2026-07-15 transaction (filed promptly; no late filing indicated).

Context

• "Sell-to-cover" transactions are routine tax-related sales when stock awards vest; they do not necessarily indicate the insider's view on the company. This sale represents withholding for RSU vesting rather than a discretionary cash-raising sale.